Shares of PB Fintech and Turtlemint plunged sharply following the Insurance Regulatory and Development Authority of India’s (IRDAI) proposal to cap insurance distribution commissions. On the second consecutive day of declines, PB Fintech’s stock fell nearly 8% to a 52-week low of ₹1,115.10, while Turtlemint shares hit their 20% lower circuit at ₹87.30, marking an all-time low. The sell-off wiped billions off their market values on September 25, 2026, according to inc42.com.
The downturn began after IRDAI issued a consultation paper proposing product- and channel-specific commission ceilings for insurance distributors. This framework would reinstate product-level commission caps over three years after they were removed in April 2023, replacing the expenses of management model. Commissions would vary depending on the insurance product, distribution channel, and the effort required to sell and service policies. PB Fintech’s market capitalization dropped to about ₹53,128.6 crore ($5.5 billion), while Turtlemint’s valuation fell to ₹2,607.6 crore ($272 million), inc42.com reported.
The proposed commission caps have unsettled the insurtech sector, which had benefited from the removal of product-level limits in 2023. PB Fintech’s shares have declined approximately 39% over two sessions, and Turtlemint’s by about 35% from pre-sell-off levels. The move signals a regulatory shift aimed at controlling distribution costs, which could impact revenue models for insurance aggregators and brokers. This development follows a broader trend of regulatory tightening in India’s fintech and insurtech markets, as documented by inc42.com.
At 12:21 IST on September 25, PB Fintech was trading 5.12% lower at ₹1,148.10, while Turtlemint was down 18.84% at ₹88.55, reflecting ongoing market volatility. The consultation paper remains open for feedback before any final rules are implemented, according to inc42.com.